Axsome Therapeutics, Inc.

Direct answer

Axsome Therapeutics, Inc. is publicly traded on NASDAQ under the ticker AXSM.

Axsome Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and advancing innovative treatments for a range of central nervous system (CNS) disorders within the United States. Its robust product pipeline features several promising candidates, including: AXS-05, an investigational therapy currently being developed for major depressive disorder and treatment-resistant depression. This compound is...

Can you invest in Axsome Therapeutics, Inc.?

Yes. Axsome Therapeutics, Inc. trades publicly on NASDAQ as AXSM.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Axsome Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.